news
First patient receives new engineered mRNA epigenetic
OTX-2002, a programmable epigenetic medicine is the first mRNA therapy to target MYC dysregulation and could treat hepatocellular carcinoma.
List view / Grid view
Epigenomics
article
Establishing precision medicine in Abu Dhabi
Work is underway to create a collaborative virtual research institute (VRI) to support the fundamental research and subsequent clinical translation of precision medicine in Abu Dhabi, as well as the United Arab Emirates more broadly. Here, European Pharmaceutical Review’s Hannah Balfour discusses the project with the Head of the new…
news
Inhaled blood pressure drug shows promise in treating anxiety and pain
The inhaled version of a high blood pressure drug may treat some types of anxiety and pain, reveals new research from the Centre for Addiction and Mental Health...
news
Scientists share promising results of BET and EZH2 inhibitors for lymphoma
Researchers at the TAT (Targeted Anticancer Therapies) International Congress 2018 in Paris have presented new epigenetics compounds that show early activity in lymphoma patients.
news
Blood-based epigenetic may hold clues to autism
Epigenetic data reveals immune-response pathways that may prove critical to understanding autism...
news
FDA approves blood-based colorectal cancer screening test
13 April 2016 | By Victoria White, Digital Content Producer
The FDA has approved Epigenomics’ lead product, Epi proColon, the first and only FDA-approved blood-based colorectal cancer screening test...
